dc.creator | Chatziparasidis G., Kantar A. | en |
dc.date.accessioned | 2023-01-31T07:44:20Z | |
dc.date.available | 2023-01-31T07:44:20Z | |
dc.date.issued | 2021 | |
dc.identifier | 10.1007/s00408-021-00419-9 | |
dc.identifier.issn | 03412040 | |
dc.identifier.uri | http://hdl.handle.net/11615/72684 | |
dc.description.abstract | Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infects both children and adults but epidemiological and clinical data demonstrate that children are less likely to have a severe disease course or die. Furthermore, asthmatic children show less severe disease manifestations when infected with SARS-CoV-2 comparing to adults. This review focuses on SARS-CoV-2 and childhood asthma interaction and aims at summarizing the current knowledge of the potential mechanisms that ameliorate disease symptomatology in asthmatic children. © 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature. | en |
dc.language.iso | en | en |
dc.source | Lung | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099835102&doi=10.1007%2fs00408-021-00419-9&partnerID=40&md5=6a1fde6492bffbbdc747193669d181a2 | |
dc.subject | asthma | en |
dc.subject | clinical feature | en |
dc.subject | consultation | en |
dc.subject | coronavirus disease 2019 | en |
dc.subject | human | en |
dc.subject | medical examination | en |
dc.subject | outcome assessment | en |
dc.subject | pandemic | en |
dc.subject | priority journal | en |
dc.subject | Review | en |
dc.subject | Severe acute respiratory syndrome coronavirus 2 | en |
dc.subject | age | en |
dc.subject | asthma | en |
dc.subject | asymptomatic disease | en |
dc.subject | child | en |
dc.subject | female | en |
dc.subject | host pathogen interaction | en |
dc.subject | immunology | en |
dc.subject | male | en |
dc.subject | mortality | en |
dc.subject | pathogenicity | en |
dc.subject | prognosis | en |
dc.subject | protection | en |
dc.subject | risk factor | en |
dc.subject | severity of illness index | en |
dc.subject | virology | en |
dc.subject | Age Factors | en |
dc.subject | Asthma | en |
dc.subject | Asymptomatic Diseases | en |
dc.subject | Child | en |
dc.subject | COVID-19 | en |
dc.subject | Female | en |
dc.subject | Host-Pathogen Interactions | en |
dc.subject | Humans | en |
dc.subject | Male | en |
dc.subject | Prognosis | en |
dc.subject | Protective Factors | en |
dc.subject | Risk Factors | en |
dc.subject | SARS-CoV-2 | en |
dc.subject | Severity of Illness Index | en |
dc.subject | Springer | en |
dc.title | COVID-19 in Children with Asthma | en |
dc.type | other | en |